L. G. T. Morris

This study develops a logistic regression model to predict immune checkpoint blockade response and survival in cancer patients using common clinical and genomic features.

This study shows that MEK1/2 inhibition temporarily improves the tumor immune microenvironment, enhancing immunotherapy effectiveness in head and neck cancer by reducing suppressive myeloid cells and boosting CD8+ T cell activity.

The paper investigates how immune factors influence the predictive power of tumor mutational burden (TMB) for immunotherapy response across cancer types.

This study evaluates the predictive value of ThyroSeq v2 across four institutions for indeterminate thyroid nodules, finding variable positive predictive values and differences in malignancy risk assessment.

This study identifies prevalent oncogenic gene fusions in myoepithelial carcinoma through genomic analysis, highlighting TGFBR3-PLAG1 as a key fusion and potential therapeutic target.